EA199800650A1 - Новые соединения - Google Patents

Новые соединения

Info

Publication number
EA199800650A1
EA199800650A1 EA199800650A EA199800650A EA199800650A1 EA 199800650 A1 EA199800650 A1 EA 199800650A1 EA 199800650 A EA199800650 A EA 199800650A EA 199800650 A EA199800650 A EA 199800650A EA 199800650 A1 EA199800650 A1 EA 199800650A1
Authority
EA
Eurasian Patent Office
Prior art keywords
optionally substituted
lower alkoxy
substituted
oxo
hydroxy
Prior art date
Application number
EA199800650A
Other languages
English (en)
Inventor
Масааки Матсуо
Кацуо Окумура
Синдзи Сигенага
Хироаки Нисимура
Хироси Матсуда
Дайдзиро Хагивара
Тадаси Терасака
Original Assignee
Фудзисава, Фармасьютикал Ко., Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9601235.6A external-priority patent/GB9601235D0/en
Priority claimed from AUPO1111A external-priority patent/AUPO111196A0/en
Application filed by Фудзисава, Фармасьютикал Ко., Лтд filed Critical Фудзисава, Фармасьютикал Ко., Лтд
Publication of EA199800650A1 publication Critical patent/EA199800650A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Настоящее изобретение относится к новым производным тиазолилбензофурана формулы (I):где Rпредставляет низший алкил; L представляет одинарную связь или низший алкилен, необязательно замещенный арилом, оксо или гидрокси; и Q представляет гетероциклическую группу, необязательно замещенную одним или несколькими подходящими заместителями; или низший алкокси, замещенный арилом, который замещен одним или несколькими подходящими заместителями, по меньшей мере, один из которых представляет низший алкокси, необязательно замещенный циано, защищенным карбокси, карбокси, низшим алкиленом, гетероциклической группой, необязательно замещенной оксо, или амидино, необязательно замещенным гидрокси или низшим алкокси, или их солям, которые обладают активностью в качестве антагонистов или ингибиторов лейкотриена и SRS-A.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199800650A 1996-01-22 1997-01-17 Новые соединения EA199800650A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9601235.6A GB9601235D0 (en) 1996-01-22 1996-01-22 Novel compounds
AUPO1111A AUPO111196A0 (en) 1996-07-18 1996-07-18 Novel compounds
PCT/JP1997/000073 WO1997027190A1 (en) 1996-01-22 1997-01-17 Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
EA199800650A1 true EA199800650A1 (ru) 1999-02-25

Family

ID=25645218

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800650A EA199800650A1 (ru) 1996-01-22 1997-01-17 Новые соединения

Country Status (12)

Country Link
US (1) US5994378A (ru)
EP (2) EP1170009B1 (ru)
JP (1) JP2000503984A (ru)
KR (1) KR19990076788A (ru)
CN (1) CN1209809A (ru)
AT (2) ATE216384T1 (ru)
CA (1) CA2244189A1 (ru)
DE (2) DE69728581D1 (ru)
EA (1) EA199800650A1 (ru)
ES (1) ES2171878T3 (ru)
HU (1) HUP9900424A2 (ru)
WO (1) WO1997027190A1 (ru)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9919413D0 (en) 1999-08-18 1999-10-20 Zeneca Ltd Chemical compounds
WO2001032621A1 (fr) * 1999-10-29 2001-05-10 Wakunaga Pharmaceutical Co., Ltd. Nouveaux derives d'indole, et medicaments contenant lesdits derives comme principe actif
AU2002246397B2 (en) * 2001-04-16 2005-03-24 Tanabe Seiyaku Co., Ltd. Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
BRPI0211844B8 (pt) 2001-08-10 2021-05-25 Nippon Chemiphar Co composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica
JP4276074B2 (ja) 2001-10-12 2009-06-10 日本ケミファ株式会社 ペルオキシソーム増殖剤応答性受容体δの活性化剤
JP2008506702A (ja) * 2004-07-14 2008-03-06 ピーティーシー セラピューティクス，インコーポレーテッド Ｃ型肝炎を治療するための方法
WO2006044000A1 (en) * 2004-10-12 2006-04-27 Decode Genetics Sulfonamide pert-substituted bicyclics for occlusive artery disease
WO2006046683A1 (en) * 2004-10-25 2006-05-04 Astellas Pharma Inc. Thiazolylbenzofuran derivatives as leukotriene and prostaglandin d2 receptor antagonists
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) * 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
EP1984334B1 (en) * 2006-02-15 2014-04-09 Allergan, Inc. Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
CN101460458A (zh) * 2006-02-15 2009-06-17 阿勒根公司 具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
PL2014652T3 (pl) 2006-04-18 2015-02-27 Nippon Chemiphar Co Czynnik aktywujący receptor aktywowany przez proliferatory peroksysomów
DE102006021733A1 (de) * 2006-05-09 2007-11-22 Bayer Healthcare Ag 3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung
KR20090018934A (ko) * 2006-05-16 2009-02-24 디코드 제네틱스 이에이치에프 7-(아크릴로일)인돌의 제조방법
DE102006043443A1 (de) * 2006-09-15 2008-03-27 Bayer Healthcare Ag Neue aza-bicyclische Verbindungen und ihre Verwendung
CN101668741A (zh) * 2007-01-11 2010-03-10 阿勒根公司 具有鞘氨醇-1-磷酸(s1p)受体拮抗剂生物学活性的6-取代吲哚-3-羧酸酰胺化合物
US8524917B2 (en) 2007-01-11 2013-09-03 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
KR101871665B1 (ko) 2008-04-15 2018-06-27 닛뽕 케미파 가부시키가이샤 퍼옥시좀 증식제 활성화 수용체의 활성화제
DE102008063992A1 (de) 2008-12-19 2010-09-02 Lerner, Zinoviy, Dipl.-Ing. Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung
US8343970B2 (en) 2010-03-12 2013-01-01 Omeros Corporation PDE10 inhibitors and related compositions and methods
CN103649079B (zh) 2010-12-22 2016-11-16 Abbvie公司 丙型肝炎抑制剂及其用途
AU2014220801A1 (en) 2013-02-21 2015-09-10 Adverio Pharma Gmbh Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate
NZ716494A (en) 2014-04-28 2017-07-28 Omeros Corp Processes and intermediates for the preparation of a pde10 inhibitor
NZ716462A (en) 2014-04-28 2017-11-24 Omeros Corp Optically active pde10 inhibitor
DK3186233T3 (da) 2014-08-29 2021-11-22 Chdi Foundation Inc Prober til billeddannelse af huntingtin-protein
EP3285760A4 (en) 2015-04-24 2018-09-26 Omeros Corporation Pde10 inhibitors and related compositions and methods
JP2018535969A (ja) 2015-11-04 2018-12-06 オメロス コーポレーション Ｐｄｅ１０阻害剤の固体状態形態
MX2020004666A (es) 2017-11-17 2022-01-26 Cellix Bio Private Ltd Compuestos de pilocarpina con ácido lipoico para el tratamiento de trastornos oculares.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2600644B2 (ja) * 1991-08-16 1997-04-16 藤沢薬品工業株式会社 チアゾリルベンゾフラン誘導体
JPH07179856A (ja) * 1993-12-21 1995-07-18 Canon Inc 液晶性化合物、これを含有する液晶組成物、該液晶組成物を用いた液晶素子並びにこれらを用いた表示方法、表示装置

Also Published As

Publication number Publication date
EP0880519A1 (en) 1998-12-02
CA2244189A1 (en) 1997-07-31
EP1170009A3 (en) 2002-01-16
ATE216384T1 (de) 2002-05-15
DE69712042D1 (de) 2002-05-23
DE69728581D1 (de) 2004-05-13
ATE263561T1 (de) 2004-04-15
EP1170009B1 (en) 2004-04-07
DE69712042T2 (de) 2002-10-02
EP1170009A2 (en) 2002-01-09
HUP9900424A2 (hu) 1999-05-28
WO1997027190A1 (en) 1997-07-31
EP0880519B1 (en) 2002-04-17
CN1209809A (zh) 1999-03-03
ES2171878T3 (es) 2002-09-16
KR19990076788A (ko) 1999-10-15
JP2000503984A (ja) 2000-04-04
US5994378A (en) 1999-11-30

Similar Documents

Publication Publication Date Title
EA199800650A1 (ru) Новые соединения
EA199800051A1 (ru) Производные бензамида и их применение в качестве антагонистов вазопрессина
EA200100310A1 (ru) Кислородсодержащие гетероциклические соединения
DK1157998T3 (da) Heterocykliske forbindelser, mellemprodukter derfor og elastaseinhibitorer
ES557664A0 (es) Un procedimiento para la sintesis de derivados de imidazol.
NO20002589D0 (no) Bifenylamidinderivater
EA200301317A1 (ru) Производные аминохинолина и его применение в качестве лигандов аденозина a3
ME00444B (me) Postupak za pripremanje visoko čistog perindoprila i intermedijera korisnih u sintezama
ATE282599T1 (de) Imidazolverbindungen und ihre verwendung als adenosindeaminase-inhibitoren
ATE69050T1 (de) Organische verbindungen und ihre pharmazeutische verwendung.
ID25477A (id) Turunan-turunan spiropiperidin
YU62801A (sh) Derivati 4-heterociklilsulfonamidil-6-metoksi-5-(2-metoksi- fenoksi)-2-piridil- piridimina, njihovo dobivanje i primena kao antagonisti endotelinskih receptora
ES2093838T3 (es) Inhibidor de fosfolipasa a2.
TR200002803T2 (tr) MRP1 inhibe etmek için yöntemler.
DE3764277D1 (de) 6-ketoprostaglandin-e1-derivate.
ATE151750T1 (de) 3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind
ATE259346T1 (de) Benflumentolderivative und ihre verwendung gegen parasitäre protozoen und trematoden
EA199800931A1 (ru) Способ получения ингибиторов фосфодиэстеразы iv
ES8403459A1 (es) Un procedimiento para la preparacion de hexahidroindazolo o hexahidroisoindolo-isoquinolinas 6-sustituidas.
GEP19981168B (en) Benzimidazole derivatives and pharmaceutically acceptable salts thereof, intermediate compounds, method of their reception, stable crystals, a composition for inhibition of angiotensin ii